Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-11

FDA Approved: FENOFIBRATE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved Chartwell RX, LLC's original application for a generic fenofibrate product used to treat hyperlipidemia, hypertriglyceridemia, and mixed dyslipidem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

ORIG AP for FENOFIBRATE (FENOFIBRATE)